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Anthelmintic resistance has been increasingly reported in cattle worldwide over the last decade,
although reports from Europe are more limited. The objective of the present study was to evaluate the
efﬁcacy of injectable formulations of ivermectin and moxidectin at 0.2 mg per kg bodyweight against
naturally acquired gastro-intestinal nematodes in cattle. A total of 753 animals on 40 farms were enrolled
in Germany (12 farms), the UK (10 farms), Italy (10 farms), and France (8 farms). Animals were selected
based on pre-treatment faecal egg counts and were allocated to one of the two treatment groups. Each
treatment group consisted of between 7 and 10 animals. A post-treatment faecal egg count was per-
formed 14 days (±2 days) after treatment. The observed percentage reduction was calculated for each
treatment group based on the arithmetic mean faecal egg count before and after treatment. The resis-
tance status was evaluated based on the reduction in arithmetic mean faecal egg count and both the
lower and upper 95% conﬁdence limits. A decreased efﬁcacy was observed in half or more of the farms in
Germany, France and the UK. For moxidectin, resistance was conﬁrmed on 3 farms in France, and on 1
farm in Germany and the UK. For ivermectin, resistance was conﬁrmed on 3 farms in the UK, and on 1
farm in Germany and France. The remaining farms with decreased efﬁcacy were classiﬁed as having an
inconclusive resistance status based on the available data. After treatment Cooperia spp. larvae were
most frequently identiﬁed, though Ostertagia ostertagi was also found, in particular within the UK and
Germany. The present study reports lower than expected efﬁcacy for ivermectin and moxidectin (based
on the reduction in egg excretion after treatment) on European cattle farms, with conﬁrmed anthel-
mintic resistance on 12.5% of the farms.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).(T. Geurden), christophe.
angipane@unipd.it (A.F. di
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indu.vanimisetti@zoetis.com
Bartram), md@sund.ku.dk
ript.
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Gastro-intestinal nematodes are very common in cattle and
can cause pathology which impairs the health and welfare of
infected animals, therefore resulting in decreased production.
The use of broad spectrum anthelmintic drugs has been the
backbone of worm management for nearly 40 years. Thisty for Parasitology. This is an open access article under the CC BY license (http://
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resistant worms worldwide. The high prevalence of anthel-
mintic resistance and even multidrug resistance in sheep is
redeﬁning how anthelmintics are used in parasite control pro-
grams. Anthelmintic resistance to both benzimidazole and
macrocyclic lactone compounds has now also been reported in
cattle (Sutherland and Leathwick, 2011). For the macrocyclic
lactone compounds, anthelmintic resistance in cattle has mainly
been reported in the dose-limiting nematode Cooperia spp.
(Soutello et al., 2007; Condi et al., 2009; Gasbarre et al., 2009;
Edmonds et al., 2010; El-Abdellati et al., 2010a,b; McArthur
et al., 2011; Bartley et al., 2012; Leathwick and Miller, 2013) and
to a far lesser extent in Ostertagia ostertagi (Demeler et al., 2009;
Areskog et al., 2013). Species belonging to the genus Cooperia are
considered to be of less pathogenic signiﬁcance than Ostertagia,
although the negative effect of Cooperia punctata on cattle pro-
ductivity has been demonstrated in the US (Stromberg et al.,
2012).
The ostensibly lower rate of anthelmintic resistance detection
in cattle might in part be due to the difﬁculty in diagnosis, as
faecal egg counts tend to be less reﬂective of the adult worm
burden in cattle compared to sheep. As such, the detection of
anthelmintic resistance based on faecal egg counts is prone to
more uncertainty in cattle. Some recommendations to minimise
diagnostic uncertainty include the use of arithmetic means over
geometric means to calculate anthelmintic efﬁcacy (Dobson et al.,
2009), the use of individual based group means with pre- and
post-treatment individual faecal egg counts (Calvete and Uriarte,
2013), and the preferred use of diagnostic methods with higher
analytic sensitivity to minimise inaccuracies in populations with
low baseline faecal egg count (Levecke et al., 2011). It is also
important to obtain an adequate sample size, although the num-
ber of animals with an adequate infection for enrolment can be
limited under ﬁeld conditions. To account for the problems asso-
ciated with smaller sample sizes, the use of parametric methods
such as Markov chain Monte Carlo within a Bayesian framework
have been advocated in equine studies for all group sizes smaller
than 50 animals, in order to avoid erroneous inference about the
true efﬁcacy of anthelmintics in the ﬁeld (Denwood et al., 2010).
Bayesian methods have also more recently been advocated by
other authors (Dobson et al., 2012; Torgerson et al., 2014). Non-
parametric bootstrapping has also been considered as a potential
analysis method (Vidyashankar et al., 2007), but it has been found
to be inappropriate for smaller sample sizes (Denwood et al.,
2010), and does not produce correct results with observed re-
ductions of 100% (Denwood et al., 2010; Dobson et al., 2012;
Torgerson et al., 2014).
In addition to the method of statistical analysis, the interpre-
tation of the efﬁcacy results and the deﬁnition of anthelmintic
resistance have been debated. The current WAAVP (World Associ-
ation for the Advancement of Veterinary Parasitology) guidelines
(Coles et al., 1992) state that anthelmintic resistance is present
when the efﬁcacy is below 95% and when the lower 95% conﬁdence
limit is below 90%, and that anthelmintic resistance is suspected if
only one of the two criteria applies. More recently, there have been
recommendations to include the upper 95% conﬁdence limit in the
assessment of the true resistance status (Lyndal-Murphy et al.,
2014), which distinguishes between the two situations where
anthelmintic resistance is possible but not certain, and where
anthelmintic resistance has been conﬁrmed.
The objective of the current study was to obtain more infor-
mation on anthelmintic resistance in cattle in Europe. The efﬁcacy
of injectable formulations of ivermectin and moxidectin was eval-
uated in naturally infected cattle in four major cattle markets across
Europe.2. Materials and methods
2.1. Study design
This study was designed as a multi-site ﬁeld efﬁcacy study in
Germany, France, the UK and Italy. The anthelmintic efﬁcacy was
assessed in cattle naturally infected with gastro-intestinal nema-
todes. The study farms were selected based on the previous use of
macrocyclic lactones as the backbone for parasite management. On
each farm, all animals grazed the same pasture before and
throughout the 14 day evaluation period. The study used a rando-
mised complete block design for each farm, with the individual
animal as the experimental unit. In accordance with current
guidelines, a faecal egg count was used to select animals for
treatment. In order to ensure an adequate number of animals with a
positive faecal egg count for randomisation (a target of 20 animals),
individual faecal samples from 20 to 50 animals were screened at
each farm prior to treatment.
On each farm, animals were paired into blocks by descending
pre-treatment faecal egg count. Within each block of two, the an-
imals were randomly allocated to one of the two treatment groups.
On Day 0, theweight of the allocated animals was determined using
a girth tape. Animals were treated with injectable formulations of
either ivermectin (Ivomec® Merial) or moxidectin (Cydectin 1%®
Zoetis), both at 0.2 mg/kg bodyweight. On Day 14 (±2 days), indi-
vidual faecal egg counts were performed for all animals selected for
treatment. Faecal egg counts were performed using a modiﬁed
McMaster technique, with a sensitivity of 12.5 eggs per gram of
faeces in all countries except France (detection limit: 15 eggs per
gram of faeces). Coprocultures were performed for larval identiﬁ-
cation (VanWyk andMayhew, 2013), based on a single bulk sample
(before treatment) or a bulk sample per treatment group (after
treatment). Laboratory personnel involved in the faecal egg count
and/or the larval identiﬁcation were blinded to the allocation of
animals to treatment. The in vivo procedures occurred after ethical
review and according to state, national, or international
regulations.2.2. Statistical analysis
At each farm, the pre-treatment and post-treatment arithmetic
mean faecal egg counts were used to calculate the efﬁcacy for each
of the treatment groups using the following formula:
%reduction¼100
ðpretreatmentcountÞðposttreatmentcountÞ
pretreatmentcount
Where possible, the percentage reduction per nematode species
(Ostertagia and Cooperia) was calculated. A bootstrap analysis
approach based on Vidyashankar et al. (2007) was used to estimate
the arithmetic mean faecal egg count reduction per treatment and
the 95% conﬁdence intervals. For each dataset, new values for the
pre- and post-treatment counts were sampled with replacement
from the observed counts, and the bootstrapped efﬁcacy was
calculated as described above. This was repeated 1000 times and
the 95% conﬁdence intervals taken as the 2.5 and 97.5 percentiles of
the resulting distribution of bootstrapped efﬁcacies. All statistical
analyses were performed using R (R Core Team, 2015).2.3. Interpretation of results
The anthelmintic resistance status was interpreted using the
method described by Lyndal-Murphy et al. (2014), which is based
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1992) but also considers the upper 95% conﬁdence limit as well
as the lower 95% conﬁdence limit and the percentage reduction.
The treatment was classiﬁed as either efﬁcacious, having conﬁrmed
anthelmintic resistance, or being inconclusive based on the
following criteria:
 Efﬁcacious: percentage reduction and upper 95% conﬁdence
limit above 95% and lower 95% conﬁdence limit above 90%.
 Conﬁrmed anthelmintic resistance: percentage reduction and
upper 95% conﬁdence limit below 95% and lower 95% conﬁ-
dence limit below 90%.
 Inconclusive: neither of the above criteria fulﬁlled.
Datasets with 100% observed efﬁcacy were tentatively classiﬁed
as efﬁcacious in accordance with these criteria, however these
classiﬁcations should not be considered as deﬁnitive because the
lower 95% conﬁdence intervals produced using non-parametric
bootstrapping for these datasets cannot be relied upon (Denwood
et al., 2010; Dobson et al., 2012; Torgerson et al., 2014).
2.4. Comparison of the sampling assumptions and analytical
methods
In order to explore the statistical consequences and implications
of the standard protocol followed for this study, data from the 80
trials were re-analysed under three sampling assumptions including
the screened data as described above. To generate the second group
of datasets, the entire pre-treatment data were considered. This
included data from animals that were not enrolled in the treatment
groups due to a low or negative faecal egg count from this sample
(unscreened data). Themotivationwas to correct for regression to the
mean, induced by using the same faecal egg count sample as both
the screening and pre-treatment sample, which would be expected
to introduce a bias in the estimated efﬁcacy calculation. The third
procedure involved extending the ﬁrst procedure to utilise the pre-
treatment data from both treatment groups in order to reduce the
uncertainty in the estimated efﬁcacy (grouped data).
All three datasets from each of the 80 trials were analysed using
two statistical methods: a modiﬁed non-parametric bootstrap
method, and an Markov chain Monte Carlo method. The latter was
modiﬁed from Denwood et al. (2010) to allow an individual animal
efﬁcacy ﬁtted to those animals for which a post-treatment faecal egg
count was observed. This approach explicitly controls for several
levels of within individual extra-Poisson variance, as described by
Denwood et al. (2012). These statistical analyses were done in R (R
Core Team, 2015), with Markov chain Monte Carlo results obtained
using the bayescount package (Denwood, 2015). Full details of these
methods are given in the supplementary data ﬁle.
3. Results
A total of 40 farms and 753 animals were included in this study:
12 farms in Germany with 235 animals, 10 farms each in Italy (179
animals) and the UK (197 animals) and 8 farms (142 animals) in
France. In addition to an overview of the efﬁcacy results by country,
the number of animals in each country is provided in Table 1. The
number of animals enrolled in each treatment group varied be-
tween seven and ten (see Tables 2e5). Of the 80 treatment groups
in the study, 54 groups had ten animals, 14 groups had nine ani-
mals, 6 groups had eight animals, 5 groups had seven animals and 1
group had six animals included in the analysis. For some animals, a
faecal sample could not be collected after treatment.
The bulk coprocultures before and after treatment provide
further insight into which nematode species are potentiallyinvolved in the decreased efﬁcacy or conﬁrmed anthelmintic
resistance. The data are presented per farm in Tables 2e5 In Table 6,
an overview of the efﬁcacy against Cooperia and Ostertagia, based
on the reduction in mean faecal egg counts and the larval identi-
ﬁcation before and after treatment is provided.
3.1. Germany
The results in Germany are summarised in Table 2. The study
was conducted from August 2011 to September 2012 on 12 dairy
farms in Northern Germany in the regions of Lower Saxony (GE01-
03, GE05-09, GE11), SchleswigeHolstein (GE04 and GE10) and
Brandenburg (GE12).
The baseline faecal egg count in Germany was medium to high,
with an arithmetic mean faecal egg count between 60 and 836 eggs
per gram of faeces, and an individual faecal egg count ranging from
25 to 5587.5 eggs per gram of faeces. Moxidectin was considered to
be efﬁcacious on four farms (GE02; GE05; GE10 and GE12).
Anthelmintic resistance was conﬁrmed on 1 farm (GE01) and seven
cases were found to be inconclusive. In 5 of these cases, the species-
speciﬁc efﬁcacy calculation (Table 6) indicated that the efﬁcacy was
below 95% for Cooperia and Ostertagia (GE07, GE11) or for Cooperia
only (GE03, GE04, GE06). Ivermectin was considered to be efﬁca-
cious on two farms (GE03 and GE04), of which the latter was
associated with an observed reduction of 100%. Conﬁrmed
anthelmintic resistance was identiﬁed on the same farm as for
moxidectin (GE01). Nine cases were found to be inconclusive. In 5
of these cases, the species-speciﬁc efﬁcacy calculation (Table 6)
indicated that the efﬁcacy was below 95% for Cooperia and Oster-
tagia (GE07, GE08, GE12) or for Cooperia only (GE11, GE09). Before
treatment, O. ostertagi was identiﬁed in all farms and Cooperia spp.
in all but one of the farms. Small percentages of Trichostongylus spp.
were also identiﬁed (data not shown). Overall, Cooperia spp. was
the most prevalent nematode after treatment. Nevertheless,
O. ostertagiwas identiﬁed in eight of the tenmoxidectin and in nine
of the ten ivermectin treatment groups fromwhich larvae could be
retrieved after treatment.
3.2. Italy
The results in Italy are summarised in Table 3. The study was
conducted in beef cattle farms from October to December 2012 in
the northern part of Italy (Veneto region: IT01-05) and from
December 2011 to February 2012 in the southern part of Italy
(Apulia region: IT06-10).
The baseline faecal egg count in Italy was low to medium, with
an arithmetic mean faecal egg count between 35 and 131 eggs per
gram of faeces, and an individual faecal egg count ranging from 25
to 450 eggs per gram of faeces. Moxidectin was considered to be
efﬁcacious on nine farms, all of which were associated with a 100%
observed reduction. On one farm (IT05) in northern Italy the results
were found to be inconclusive. Ivermectin was found to be efﬁca-
cious on seven farms (two farms in northern Italy and ﬁve in
southern Italy), all of which were associated with a 100% observed
reduction. The results of the remaining three farms (IT01, IT02 and
IT03) were inconclusive.
Before treatment Haemonchus spp. was the only worm identi-
ﬁed on all farms, with one exception (IT01: which also had Cooperia
and Oesophagostomum; data not shown). The only nematode
identiﬁed after treatment was Haemonchus spp.
3.3. United Kingdom
The results in the UK are summarised in Table 4. The study was
conducted on ﬁve dairy farms (UK06-10) in Northumberland from
Table 1
The number of farms with adequate efﬁcacy (EFF), conﬁrmed anthelmintic resistance (CAR) or inconclusive (INC) for ivermectin (IVM) and moxidectin (MOX), and the number
of farms with CAR for both IVM and MOX. The number of farms (N farms), and the number of animals per treatment group (N animals) are provided per country.
Country N farms MOX IVM CAR for IVM and MOX
N animals EFF CAR INC N animals EFF CAR INC
Germany 12 118 4 1 7 117 2 1 9 2
Italy 10 88 9 0 1 91 7 0 3 0
UK 10 99 4 1 5 98 3 3 4 4
France 8 71 3 3 2 71 4 1 3 4
Total 40 376 20 5 15 377 16 5 19 10
Table 2
The arithmeticmean (AM), minimum (MIN) andmaximum (MAX) faecal egg counts before (pre) and after (post) treatment for each treatment group on the 12 farms (GE01-12)
in Germany. The number of animals in each treatment group (n) and the number of animals with a positive faecal egg count after treatment (n pos) are provided, along with the
% larvae before and after treatment (Oo¼Ostertagia ostertagi and C¼ Cooperia spp). The percentage (%) efﬁcacy is provided calculated based on the arithmetic group mean,
along with the lower (L95) and upper (U95) 95% conﬁdence limits. The anthelmintic resistance status (Status) is provided as EFF (efﬁcacious), conﬁrmed anthelmintic
resistance (CAR) or Inconclusive (INC).
Farm Treatment Pre Post Efﬁcacy Larvae pre Larvae post
n AM MIN MAX n pos AM MIN MAX % L95 U95 Status Oo C Oo C
GE01 MOX 10 260 75 550 8 58 0 187.5 76.8 56.9 90.4 CAR 44 56 3 97
IVM 10 258 62.5 475 9 55 0 150 78.3 63.3 88.4 CAR 3 97
GE02 MOX 10 75 25 187.5 2 3 0 12.5 96.5 91.3 100.0 EFF 100 0 100 0
IVM 10 75 37.5 175 2 4 0 25 94.9 86.8 100.0 INC 90 10
GE03 MOX 10 133 12.5 625 3 9 0 62.5 92.0 75.0 100.0 INC 77 22 0 100
IVM 10 109 12.5 475 1 1 0 12.5 98.7 94.6 100.0 EFF NL
GE04 MOX 10 89 25 325 1 4 0 37.5 95.5 82.4 100.0 INC 40 60 0 100
IVM 10 129 25 587.5 0 0 0 0 100.0 100.0 100.0 EFF 0 100
GE05 MOX 10 836 62.5 5587.5 6 15 0 37.5 97.3 91.1 99.5 EFF 20 80 2 95
IVM 10 465 37.5 2212.5 5 18 0 75 95.2 85.7 99.1 INC 2 98
GE06 MOX 10 106 12.5 387.5 5 23 0 125 77.2 37.3 96.7 INC 21 79 5 95
IVM 10 96 12.5 262.5 2 4 0 25 95.7 87.3 100.0 INC 5 95
GE07 MOX 8 78 12.5 225 4 8 0 25 89.0 76.5 97.4 INC 4 95 6 94
IVM 7 75 25 200 3 7 0 25 89.9 73.9 98.4 INC 30 67
GE08 MOX 10 69 25 150 3 4 0 12.5 94.4 88.0 98.6 INC 91 6 NL
IVM 10 66 12.5 137.5 2 20 0 175 69.6 8.3 100.0 INC 24 76
GE09 MOX 10 64 12.5 212.5 4 9 0 25 85.0 64.7 97.3 INC 43 57 NL
IVM 10 60 12.5 162.5 2 3 0 12.5 95.7 88.6 100.0 INC 10 90
GE10 MOX 10 101 37.5 237.5 2 3 0 12.5 97.5 93.8 100.0 EFF 31 69 13 87
IVM 10 74 12.5 175 3 5 0 25 92.8 83.3 98.6 INC NL
GE11 MOX 10 103 50 175 4 13 0 50 87.5 75.0 97.1 INC 44 56 29 71
IVM 10 114 50 250 3 5 0 25 95.5 89.6 100.0 INC 9 91
GE12 MOX 10 86 37.5 200 3 4 0 12.5 95.4 90.0 99.2 EFF 35 64 13 88
IVM 10 129 37.5 650 5 66 0 450 36.6 0.00 95.3 INC 20 80
NL ¼ no larvae were found in the coproculture. MOX ¼ moxidectin injectable. IVM ¼ ivermectin injectable.
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the region of West Sussex from August 2011 to October 2012.
The baseline faecal egg count in the UK was medium to high,
with an arithmetic mean faecal egg count between 95 and 722 eggs
per gram of faeces, and an individual faecal egg count ranging from
37.5 to 3075 eggs per gram of faeces. It is interesting to note that on
farms UK02 and UK14, all treated animals were excreting eggs by 14
days after ivermectin and moxidectin treatment. Moxidectin was
considered to be efﬁcacious on four farms (UK09, UK10, UK11 and
UK13), of which one farm (UK09) was associated with a 100%
observed reduction. Anthelmintic resistance was conﬁrmed on one
farm (UK14) and ﬁve cases were found to be inconclusive. In 4 of
these cases, the species-speciﬁc efﬁcacy calculation (Table 6) indi-
cated that the efﬁcacy was below 95% for Cooperia and Ostertagia
(UK02) or for Cooperia only (UK07, UK08, UK12). Ivermectin was
considered to be efﬁcacious on three farms (UK07, UK09 and UK10),
of which 1 farm (UK09) was associated with a 100% observed
reduction. Conﬁrmed anthelmintic resistance was identiﬁed on
three farms (UK02, UK12 and UK14), and the results on four farms
were inconclusive. In 3 of these cases, the species-speciﬁc efﬁcacy
calculation (Table 6) indicated that the efﬁcacy was below 95% for
Cooperia and Ostertagia (UK11, UK13) or for Cooperia only (UK08).Before treatment, coprocultures were successful for nine out of
ten farms and both Cooperia spp. and O. ostertagi were identiﬁed.
The most prevalent nematode after treatment was Cooperia spp.
although O. ostertagi was also identiﬁed on seven farms after
moxidectin treatment (10e94% of the larvae) and on ﬁve farms
after ivermectin treatment (6e100% of the larvae). On one farm
(UK06), 94% of the larvae after moxidectin treatment and 100% of
the larvae after ivermectin treatment were identiﬁed as O. ostertagi.
3.4. France
The results of the eight dairy farms in France are summarised in
Table 5. The study was conducted from November 2011 to
September 2012, in the region of Nantes.
The baseline faecal egg count in France was low to medium,
with an arithmetic mean faecal egg count between 40 and 216
eggs per gram of faeces, and an individual faecal egg count
ranging from 15 to 1125 eggs per gram of faeces. Moxidectin was
considered as efﬁcacious on three farms (FR01, FR05 and FR08), all
of which were associated with a 100% observed reduction.
Conﬁrmed anthelmintic resistance was observed on three farms
(FR06, FR09 and FR12), and on two farms the results were
Table 3
The arithmetic mean (AM), minimum (MIN) andmaximum (MAX) faecal egg counts before (pre) and after (post) treatment for each treatment group on the 10 farms (IT01-10)
in Italy. The number of animals in each treatment group (n) and the number of animals with a positive faecal egg count after treatment (n pos) are provided, along with the %
larvae before and after treatment (Hae¼ Haemonchus spp. and C¼ Cooperia spp). The percentage (%) efﬁcacy calculated based on the arithmetic groupmean is provided, along
with the lower (L95) and upper (U95) 95% conﬁdence limits. The anthelmintic resistance status (Status) is provided as EFF (efﬁcacious), conﬁrmed anthelmintic resistance
(CAR) or Inconclusive (INC).
Farm Treatment Pre Post Efﬁcacy Larvae pre Larvae
post
n AM MIN MAX n pos AM MIN MAX % L95 U95 Status Hae C Hae C
IT01 MOX 10 63 25 125 0 0 0 0 100 100.0 100.0 EFF 78a 18a
IVM 9 97 50 400 3 19 0 100 77.1 36.3 100.0 INC 100 0
IT02 MOX 9 111 25 400 0 0 0 0 100 100.0 100.0 EFF 100 0
IVM 9 131 25 450 2 6 0 25 95.4 87.1 100.0 INC 100 0
IT03 MOX 6 42 25 75 0 0 0 0 100 100.0 100.0 EFF 100 0
IVM 8 41 25 100 1 6 0 50 84.6 50.0 100.0 INC 100 0
IT04 MOX 6 42 25 75 0 0 0 0 100 100.0 100.0 EFF 100 0 ND
IVM 8 50 25 200 0 0 0 0 100 100.0 100.0 EFF
IT05 MOX 7 64 25 225 1 4 0 25 93.4 71.4 100.0 INC 100 0 NL
IVM 7 39 25 100 0 0 0 0 100 100.0 100.0 EFF
IT06 MOX 10 38 25 62.5 0 0 0 0 100 100.0 100.0 EFF 100 0 ND
IVM 10 40 25 112.5 0 0 0 0 100 100.0 100.0 EFF
IT07 MOX 10 49 25 125 0 0 0 0 100 100.0 100.0 EFF 100 0 ND
IVM 10 46 25 100 0 0 0 0 100 100.0 100.0 EFF
IT08 MOX 10 46 25 87.5 0 0 0 0 100 100.0 100.0 EFF 100 0 ND
IVM 10 48 25 87.5 0 0 0 0 100 100.0 100.0 EFF
IT09 MOX 10 38 25 75 0 0 0 0 100 100.0 100.0 EFF 100 0 ND
IVM 10 35 25 50 0 0 0 0 100 100.0 100.0 EFF
IT10 MOX 10 46 25 137.5 0 0 0 0 100 100.0 100.0 EFF 100 0 ND
IVM 10 45 25 112.5 0 0 0 0 100 100.0 100.0 EFF
ND¼ for those groups with high efﬁcacy no copro-culture was performed. NL ¼ no larvae were found in the coproculture.
MOX ¼ moxidectin injectable. IVM ¼ ivermectin injectable.
a On IT01, Oesophagostomum (4%) was identiﬁed as well pre-treatment.
Table 4
The arithmetic mean (AM), minimum (MIN) and maximum (MAX) faecal egg counts before (pre) and after (post) treatment for each treatment group on the 10 farms (UK02
and UK06-14) in the UK. The number of animals in each treatment group (n) and the number of animals with a positive faecal egg count after treatment (n pos) are provided,
along with the % larvae before and after treatment (Oo¼Ostertagia ostertagi and C¼ Cooperia spp). The percentage (%) efﬁcacy calculated based on the arithmetic group mean
is provided, along with the lower (L95) and upper (U95) 95% conﬁdence limits. The anthelmintic resistance status (Status) is provided as EFF (efﬁcacious), conﬁrmed
anthelmintic resistance (CAR) or Inconclusive (INC).
Farm Treatment Pre Post Efﬁcacy Larvae
pre
Larvae post
n AM MIN MAX n pos AM MIN MAX % L95 U95 Status Oo C Oo C
UK02 MOX 10 353 37.5 800 10 35 12.5 125 89.8 80.8 95.3 INC 10 47 17 68
IVM 10 320 12.5 862.5 10 61 12.5 237.5 79.3 55.6 92.5 CAR 0 99
UK06 MOX 10 243 162.5 412.5 6 21 0 62.5 91.2 84.5 96.9 INC NL 94 6
IVM 10 234 150 350 6 13 0 50 94.6 90.6 98.0 INC 100 0
UK07 MOX 10 254 87.5 762.5 2 9 0 75 96.4 89.6 100.0 INC 41 52 0 100
IVM 10 223 75 400 2 3 0 12.5 98.8 97.0 100.0 EFF 0 90
UK08 MOX 10 170 62.5 625 7 14 0 25 91.2 83.9 96.0 INC 57 40 16 84
IVM 10 126 62.5 337.5 5 29 0 187.5 76.8 41.3 96.3 INC 6 94
UK09 MOX 10 95 50 175 0 0 0 0 100.0 100.0 100.0 EFF 69 17 NL
IVM 10 105 50 250 0 0 0 0 100.0 100.0 100.0 EFF
UK10 MOX 10 216 75 437.5 2 3 0 12.5 98.8 97.1 100.0 EFF 21 55 0 100
IVM 10 303 137.5 937.5 1 1 0 12.5 99.6 98.6 100.0 EFF 0 100
UK11 MOX 9 722 212.5 3075 4 18 0 50 97.1 92.1 99.5 EFF 21 78 32 68
IVM 9 546 187.5 2162.5 6 63 0 175 86.8 67.4 97.2 INC 29 70
UK12 MOX 10 391 125 925 6 21 0 137.5 94.5 86.2 98.8 INC 56 44 10 90
IVM 10 388 125 687.5 7 56 0 175 85.0 72.7 95.0 CAR 18 82
UK13 MOX 10 299 150 737.5 5 11 0 62.5 96.2 91.3 99.1 EFF 26 74 21 79
IVM 9 351 137.5 1137.5 5 63 0 450 80.7 44.4 98.4 INC 38 61
UK14 MOX 10 149 62.5 587.5 10 18 12.5 50 87.1 75.3 94.1 CAR 40 60 27 67
IVM 10 113 50 262.5 10 60 12.5 287.5 46.4 12.5 83.3 CAR 0 100
NL ¼ no larvae were found in the coproculture. MOX ¼ moxidectin injectable. IVM ¼ ivermectin injectable.
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FR08, FR09 and FR11), of which three farms (FR01, FR08 and FR11)
were associated with a 100% observed reduction. Anthelmintic
resistance was conﬁrmed for ivermectin on one farm (FR12), and
on three farms the results were inconclusive. The species-speciﬁc
efﬁcacy calculation (Table 6) indicated that the efﬁcacy was below
95% for Cooperia only (FR06).Before treatment, coprocultures were successful for seven out of
eight farms: Cooperia spp. was identiﬁed on seven farms and
O. ostertagi was identiﬁed on ﬁve farms. The most prevalent nem-
atodes after treatment were Cooperia spp. In France, only a small
percentage of O. ostertagi larvae were identiﬁed after ivermectin
treatment on FR09. The coproculture of FR02 and FR11 did not yield
any larvae.
Table 5
The arithmetic mean (AM), minimum (MIN) and maximum (MAX) faecal egg counts before (pre) and after (post) treatment for each treatment group on the 8 farms (FR01-12)
in France. The number of animals in each treatment group (n) and the number of animals with a positive faecal egg count after treatment (n pos) are provided, along with the %
larvae before and after treatment (Oo¼Ostertagia ostertagi and C¼ Cooperia spp). The percentage (%) efﬁcacy calculated based on the arithmetic groupmean is provided, along
with the lower (L95) and upper (U95) 95% conﬁdence limits. The anthelmintic resistance status (Status) is provided as EFF (efﬁcacious), conﬁrmed anthelmintic resistance
(CAR) or Inconclusive (INC).
Farm Treatment Pre Post Bootstrap Larvae pre Larvae post
n AM MIN MAX n pos AM MIN MAX % L95 U95 Status Oo C Oo C
FR01 MOX 9 40 15 90 0 0 0 0 100 100.0 100.0 EFF 91 9 ND
IVM 9 57 15 165 0 0 0 0 100 100.0 100.0 EFF ND
FR04 MOX 7 41 15 75 2 9 0 45 77.5 37.5 100.0 INC 76 24 NL
IVM 9 38 15 75 4 12 0 45 68.3 35.0 95.0 INC
FR05 MOX 8 168 15 465 0 0 0 0 100 100.0 100.0 EFF 0 100 ND
IVM 7 216 15 735 2 9 0 45 95.2 82.5 100.0 INC ND
FR06 MOX 9 110 15 315 6 47 0 135 52.6 12.1 86.1 CAR 6 94 0 100
IVM 9 138 15 600 3 37 0 210 68.5 2.5 98.1 INC 0 100
FR08 MOX 9 137 30 420 0 0 0 0 100 100.0 100.0 EFF 12 88 ND
IVM 9 170 30 465 0 0 0 0 100 100.0 100.0 EFF ND
FR09 MOX 10 74 15 165 6 21 0 45 70.1 43.9 87.7 CAR NL 0 100
IVM 10 176 15 1125 1 2 0 15 98.8 94.3 100.0 EFF 6 94
FR11 MOX 9 75 15 210 2 5 0 30 92.7 78.9 100.0 INC 5 95 NL
IVM 8 84 15 240 0 0 0 0 100 100.0 100.0 EFF
FR12 MOX 10 167 60 345 8 50 0 195 68.8 39.6 88.7 CAR 0 100 0 100
IVM 10 161 75 345 5 36 0 120 77.3 57.6 94.1 CAR 0 100
ND¼ for those groups with high efﬁcacy no copro-culture was performed. NL ¼ no larvae were found in coproculture. MOX ¼ moxidectin injectable. IVM ¼ ivermectin
injectable.
Table 6
The percentage efﬁcacy calculated for Cooperia and Ostertagia separately for those
treatment groups on those farms where larval identiﬁcation was available before
and after treatment (IVM ¼ ivermectin; MOX ¼moxidectin). The number of groups
with efﬁcacy lower than 95% is provided (<95%).
Cooperia spp Ostertagia spp
Farm IVM MOX IVM MOX
GE01 63% 61% 99% 98%
GE02 95% 96%
GE03 69% 100%
GE04 100% 93% 100% 100%
GE05 95% 98% 100% 100%
GE06 95% 74% 99% 95%
GE07 93% 90% 30% 85%
GE08 284% 92%
GE09 92% 99%
GE10 96% 99%
GE11 93% 84% 99% 92%
GE12 36% 94% 71% 98%
UK02 60% 86% 100% 83%
UK07 98% 93% 100% 100%
UK08 46% 83% 98% 98%
UK10 99% 97% 100% 100%
UK11 90% 98% 84% 96%
UK12 73% 89% 95% 99%
UK13 85% 96% 74% 97%
UK14 12% 87% 100% 92%
FR06 71% 55% 100% 100%
FR12 66% 70% 100% 100%
<95% 14/19 13/19 5/20 5/20
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methods
There was no signiﬁcant difference between the observed efﬁ-
cacy from the 80 trials as calculated from the grouped and un-
screened datasets, although the additional pre-treatment data
reduced the uncertainty in the true reduction. This was reﬂected in
smaller 95% conﬁdence intervals and therefore fewer datasets
classiﬁed as inconclusive for the grouped data compared to the
unscreened data (one fewer for Markov chain Monte Carlo and ﬁvefewer for the bootstrap method). However, the screened datasets
signiﬁcantly over-estimated the efﬁcacy (compared to the grouped
datasets) by an average of 2.4% over the 80 trials, and for the
bootstrap method in particular, were also associated with a ten-
dency to classify trials as efﬁcacious or inconclusive rather than
inconclusive or conﬁrmed anthelmintic resistance. Each of the 25
trials with 100% observed reductions were classiﬁed as inconclu-
sive by the Markov chain Monte Carlo method using screened, un-
screened and grouped datasets, indicating that the non-parametric
bootstrap classiﬁcation of efﬁcacious produced by the non-
parametric bootstrap is not reliable for these datasets. Based on
the grouped data from the remaining 55 trials with observed re-
ductions of less than 100%, 19 were classiﬁed as conﬁrmed
anthelmintic resistance by both Markov chain Monte Carlo and
bootstrap, 26 as inconclusive by both methods, 3 as inconclusive by
bootstrap but conﬁrmed anthelmintic resistance by Markov chain
Monte Carlo, and 7 as efﬁcacious by bootstrap but inconclusive by
Markov chain Monte Carlo. Full results of the comparison between
the analytical methods are given in the Supplementary data ﬁle.
4. Discussion
This study provides an insight into the current state of efﬁcacy of
injectable macrocyclic lactone anthelmintics on commercial cattle
farms in Germany, Italy, France and the UK. The efﬁcacy in this
study was calculated based on arithmetic group means before and
after treatment, andwas evaluated taking both the lower and upper
95% conﬁdence limit into account. This allowed the deﬁnition of
three categories: efﬁcacious, conﬁrmed anthelmintic resistance or
inconclusive (Lyndal-Murphy et al., 2014). As the criteria are based
on upper and lower 95% conﬁdence intervals as well as a calculated
percent reduction, the conclusions are dependent on accurate es-
timates obtained using an appropriate statistical method. In the
main text of this paper, standard non-parametric bootstrap
methods have been used to estimate the lower and upper 95%
conﬁdence intervals. Based on these estimates and on the inter-
pretation as suggested by Lyndal-Murphy et al. (2014), a consid-
erable number of groups were classiﬁed as inconclusive. Without
consideration of the upper 95% conﬁdence interval these groups
would be incorrectly classiﬁed as either suspected or conﬁrmed
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Using the Markov chain Monte Carlo method presented in the
supplementary ﬁle to generate 95% conﬁdence intervals, an even
larger number of groups were classiﬁed as inconclusive. This il-
lustrates the difﬁculties in accurately evaluating anthelmintic efﬁ-
cacy based on faecal egg counts in cattle, especially in bovine
populations with a low baseline faecal egg excretion. It is also
important to note that non-parametric bootstrapping is unable to
deal appropriately with an observed reduction of 100% (Denwood
et al., 2010; Dobson et al., 2012; Torgerson et al., 2014) and can
therefore yield incorrect conclusions in these situations. It is con-
cerning that no groups were classiﬁed as efﬁcacious by the Markov
chain Monte Carlo method, which suggests that larger sample sizes
are required to conﬁdently determine situations where the true
efﬁcacy is greater than 95%. Nevertheless, a number of farms with
conﬁrmed anthelmintic resistance were consistently identiﬁed, as
discussed below.
The selection of the farms in this study was based on their
previous use of macrocyclic lactone compounds which may have
led to an increased selection for the development of anthelmintic
resistance. However, the main emphasis of this study was not to
estimate the true prevalence of anthelmintic resistance on cattle
farms in the respective geographical regions. Instead, this study
intended to evaluate the current efﬁcacy situation on farms that
were selected to be representative of the relevant market, and
therefore regularly use macrocyclic lactones. The threshold for
adequate efﬁcacy was set at 95% in this study, in line with the
recommendations for macrocyclic lactones (Coles et al., 1992,
2006). Nevertheless, this general threshold does not take poten-
tial differences in regional management practices or climate factors
into account, and might therefore underestimate the anthelmintic
resistance status in regions with high baseline efﬁcacy. In Italy for
example (Geurden et al., 2014; Rinaldi et al., 2014), high efﬁcacy of
anthelmintics are commonly reported in sheep, in contrast to other
EU countries, suggesting a higher threshold for efﬁcacy might be
required. It was however preferred to use a common threshold for
all countries included, for consistency in this multi-centre study.
Speciﬁcally for Italy, this general threshold is not believed to have
resulted in an underestimation of the resistance status, given the
low number of cattle excreting eggs after treatment.
The treatment efﬁcacy in our study was evaluated based on
faecal egg count rather than worm counts, because the study ani-
mals were owned by the farmers. There are a number of limitations
associated with anthelmintic efﬁcacy evaluation based on faecal
egg counts, which have been discussed before (Dobson et al., 2009;
Denwood et al., 2010; Levecke et al., 2011, 2012). In the present
study, a diagnostic method with a low detection limit was used to
minimise the problems caused by populations with a low to me-
dium baseline faecal egg count. However, even with this detection
limit, identifying animals with an adequate infection proved chal-
lenging, reﬂecting the low baseline faecal egg count commonly
observed in cattle in Europe. As a result, up to 50 animals had to be
screened on each farm prior to treatment in order to reach the
target number of 10 animals in the majority of the treatment
groups (88% of the treatment groups had 9 or 10 animals). The
sample group sizes are in line with previous studies in Europe
(Demeler et al., 2009; Areskog et al., 2013), and with the WAAVP
guidance on anthelmintic resistance evaluation (Coles et al., 1992).
However, larger group sizes are known to increase the accuracy of
the efﬁcacy evaluation, which has been noted by several authors
using more sophisticated methods of analysis than those recom-
mended in the current WAAVP guidelines (Gill et al., 1986;
Denwood et al., 2010; Levecke et al., 2012).
Moxidectin was found to be efﬁcacious on 20 and ivermectin on
16 out of 40 farms (including the datasets with 100% reduction). Inall countries except Italy, a high number of farms with decreased
efﬁcacy were observed (ivermectin; n ¼ 24 and moxidectin;
n ¼ 20). Some of these cases with decreased efﬁcacy were listed as
inconclusive, as it is not possible to classify them as fully effective or
as conﬁrmed anthelmintic resistance based on the available faecal
egg count data. Looking however into the efﬁcacy calculation for
each parasite, it is clear that at least part of those inconclusive cases
concern a species-speciﬁc efﬁcacy below the efﬁcacy threshold for
macrocyclic lactones. The adequate or near to adequate efﬁcacy
against one nematode species sometimes masks the clear resis-
tance against the other species, and might lead to an underesti-
mation of species-speciﬁc resistance cases. Despite this
observation, conﬁrmed anthelmintic resistance was found in 5
farms (12.5%) each for moxidectin and ivermectin. In total, 7 farms
(17.5%) had conﬁrmed anthelmintic resistance in at least one of the
treatment groups, and on 3 farms (7.5%) conﬁrmed anthelmintic
resistance was identiﬁed in both groups (GE01, UK14 and FR12),
conﬁrming previous observations that ivermectin and moxidectin
share some degree of cross-resistance, but not complete cross-
resistance (Prichard et al., 2012). It is currently thought that both
drugs act via irreversibly opening of the GABA and glutamate gate-
chloride channels leading to a ﬂaccid paralysis. However, it is un-
clear which resistance mechanisms apply and it has been discussed
whether drug-speciﬁc differences in the involved mechanisms (e.g
concerning transmembrane P-glycoproteins), may contribute to
different drug efﬁcacy phenotypes (Bygarski et al., 2014).
In Italy, decreased efﬁcacy for ivermectin (associated with the
nematode Haemonchus spp.) was identiﬁed on three farms,
although the results were inconclusive. In cattle, anthelmintic
resistance against Haemonchus has previously been reported in the
US (Gasbarre et al., 2009) and in Brazil (Soutello et al., 2007).
Anthelmintic resistance was conﬁrmed in France for both iver-
mectin and moxidectin on 1 and 3 farms respectively, but this was
mainly associated with the dose-limiting nematode species Coop-
eria spp. In contrast, anthelmintic resistance in the UK and Ger-
many was due not only to the dose-limiting nematode species, but
also to the more pathogenic abomasal nematode O. ostertagi,which
was also identiﬁed in cases of conﬁrmed anthelmintic resistance.
Calculating the species-speciﬁc efﬁcacy, conﬁrms that reduced ef-
ﬁcacy is mainly observed in Cooperia, although in 25% of the farms
for which this calculation could be done, the efﬁcacy of both iver-
mectin and moxidectin against Ostertagiawas below 95% (all in the
UK and Germany). This is in contrast to previous efﬁcacy evalua-
tions of macrocyclic lactone compounds under European ﬁeld
conditions, in which decreased efﬁcacy was mostly associated with
Cooperia (Demeler et al., 2009; Bartley et al., 2012). In a recent study
in Sweden, O. ostertagi was identiﬁed on 15% of farms after iver-
mectin or doramectin treatment with topical formulations
(Areskog et al., 2013).
The suppression of the egg excretion by Cooperia spp. worms
following moxidectin treatment has been described (Condi et al.,
2009; de Graef et al., 2012; Lopes et al., 2014), potentially leading
to an overestimation of the moxidectin efﬁcacy against Cooperia
spp. based on faecal examination. However, where Cooperia spp.
larvae were identiﬁed after treatment with ivermectin on our study
farms, they were also observed on the same farm (and in similar
proportions) after treatment with moxidectin. The comparable
proportions after treatment seem to suggest that on farms with
decreased efﬁcacy of ivermectin against Cooperia, the efﬁcacy of
moxidectin was not overestimated due to a suppressed egg
excretion.
The results of the current study indicate that anthelmintic
resistance is an increasing reality in three major cattle rearing
countries in Europe, and that this concerns not only the dose-
limiting species but also O. ostertagi. This should incite the
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towards what has been referred to as a paradigm shift in parasite
control (McArthur and Reinemeyer, 2014). The key message is that
management advice should be based on a sound understanding of
the parasite epidemiology and farmmanagement, past and present,
and that the requirement for and appropriate timing of treatment
should be established based on faecal examinations. In the present
study, screening of up to 50 animals was needed to identify a suf-
ﬁcient number of animals with an adequate infection prior to
treatment. This indicates that not all animals need treatment at the
same time and that an approach with targeted treatments could be
considered. Different approaches, including Targeted Selective
Treatments programs, to decrease the selection pressure for the
development of anthelmintic resistance in ruminants, have previ-
ously been discussed (Knox et al., 2012; Charlier et al., 2014). The
use of combination anthelmintics has also been advocated, in order
to increase the farm treatment efﬁcacy and consequently prevent
the introduction of resistance genes into the worm population
(Smith, 2014) and also to protect any new anthelmintic compound
(Bartram et al., 2011; Geary et al., 2012; Knox et al., 2012). Never-
theless, any new combination anthelmintic must be used in a
sustainable manner (Lanusse et al., 2014).
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